USE OF ANTI-TNF.ALPHA.ANTIBODIES AND ANOTHER DRUG

摘要

The present invention is directed to a method of treating disorders in which TFN.alpha. activity is detrimental via biweekly, subcutaneous administration of human antibodies, preferably recombinant human antibodies, that specifically bind to human tum or necrosis factor a (hTNF.alpha.) in combination with another drug which is useful for treating the disorder. An antibody of the invention can be a full-length antibody or an antigen- binding portion thereof. Kits containing a pharmaceutical composition and instructions for dosing are also encompassed by the invention.